Lackey; Karen Elizabeth
Patent Applications and Registrations
Patent applications and USPTO patent grants for Lackey; Karen Elizabeth.The latest application filed is for "bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors".
Company Profile
0.29.35
- Lackey; Karen Elizabeth - Durham NC
- Lackey; Karen Elizabeth - Hillsborough NC
Patent Activity
| Patent | Date |
|---|---|
| Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors App 20160339027 - Carter; Malcolm Clive ; et al. | 2016-11-24 |
| Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors App 20160051551 - Carter; Malcolm Clive ; et al. | 2016-02-25 |
| Cancer Treatment Method App 20150366868 - Lackey; Karen Elizabeth ; et al. | 2015-12-24 |
| Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 9,199,973 - Carter , et al. December 1, 2 | 2015-12-01 |
| Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors App 20150065527 - Carter; Malcolm Clive ; et al. | 2015-03-05 |
| Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 8,912,205 - Carter , et al. December 16, 2 | 2014-12-16 |
| Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors App 20130310562 - Carter; Malcolm Clive ; et al. | 2013-11-21 |
| Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 8,513,262 - Carter , et al. August 20, 2 | 2013-08-20 |
| Cancer treatment method Grant 8,444,988 - Lackey , et al. May 21, 2 | 2013-05-21 |
| Cancer Treatment Method App 20120058113 - Lackey; Karen Elizabeth ; et al. | 2012-03-08 |
| Cancer Treatment Method App 20110312982 - Lackey; Karen Elizabeth ; et al. | 2011-12-22 |
| Compounds And Methods Of Treatment App 20110053934 - ANGELL; RICHARD MARTYN ; et al. | 2011-03-03 |
| Cancer Treatment Method App 20100249160 - Lackey; Karen Elizabeth ; et al. | 2010-09-30 |
| Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors App 20100120804 - Carter; Malcom Clive ; et al. | 2010-05-13 |
| Heterocyclic compounds Grant 7,507,741 - Cockerill , et al. March 24, 2 | 2009-03-24 |
| Compounds and Methods of Treatment App 20080234267 - LACKEY; Karen Elizabeth | 2008-09-25 |
| Substituted oxindole derivatives as tyrosine kinase inhibitors Grant 7,338,966 - Lackey , et al. March 4, 2 | 2008-03-04 |
| Heterocyclic Compounds App 20080004294 - Cockerill; George Stuart ; et al. | 2008-01-03 |
| Heterocyclic Compounds App 20070238875 - CARTER; Malcolm Clive ; et al. | 2007-10-11 |
| Heterocyclic compounds Grant 7,265,123 - Cockerill , et al. September 4, 2 | 2007-09-04 |
| Cancer Treatment Method App 20070148261 - LACKEY; Karen Elizabeth ; et al. | 2007-06-28 |
| Heterocyclic Compounds App 20070093512 - COCKERILL; George Stuart ; et al. | 2007-04-26 |
| Anilinoquinazaolines as protein tyrosine kianse inhibitors Grant 7,189,734 - Cockerill , et al. March 13, 2 | 2007-03-13 |
| Heterocyclic Compounds App 20070015775 - Carter; Malcom Clive ; et al. | 2007-01-18 |
| Cancer treatment method Grant 7,141,576 - Lackey , et al. November 28, 2 | 2006-11-28 |
| Compounds Grant 7,129,253 - Glennon , et al. October 31, 2 | 2006-10-31 |
| Heterocyclic compounds Grant 7,109,333 - Carter , et al. September 19, 2 | 2006-09-19 |
| Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects Grant 7,105,529 - Davis , et al. September 12, 2 | 2006-09-12 |
| Anilinoquinazaolines as protein tyrosine kianse inhibitors App 20060189637 - Cockerill; George Stuart ; et al. | 2006-08-24 |
| Anilinoquinazaolines as protein tyrosine kinase inhibitors Grant 7,084,147 - Cockerill , et al. August 1, 2 | 2006-08-01 |
| Substituted oxindole derivatives as tyrosine kinase inhibitors Grant 7,071,217 - Dickerson , et al. July 4, 2 | 2006-07-04 |
| Chemical compounds App 20060128745 - Lackey; Karen Elizabeth ; et al. | 2006-06-15 |
| Chemical compounds Grant 7,015,231 - Lackey , et al. March 21, 2 | 2006-03-21 |
| Oxindole derivatives App 20050282810 - Harris, Philip Anthony ; et al. | 2005-12-22 |
| Pyrazolopyrimidines as kinase inhibitors App 20050267133 - Brown, Matthew Lee ; et al. | 2005-12-01 |
| Oxindole derivatives Grant 6,964,977 - Harris , et al. November 15, 2 | 2005-11-15 |
| Substituted oxindole derivatives as tyrosine kinase inhibitors App 20050228025 - Dickerson, Scott Howard ; et al. | 2005-10-13 |
| Anilinoquinazolines as protein tyrosine kinase inhibitors Grant 6,933,299 - Cockerill , et al. August 23, 2 | 2005-08-23 |
| Anilinoquinazaolines as protein tyrosine kianse inhibitors App 20050143401 - Cockerill, George Stuart ; et al. | 2005-06-30 |
| Heterocyclic compounds App 20050130996 - Carter, Malcolm Clive ; et al. | 2005-06-16 |
| 3-(anilinomethylene)oxindoles Grant 6,818,632 - Glennon , et al. November 16, 2 | 2004-11-16 |
| Substituted aza-oxindole derivatives Grant 6,815,439 - Harris , et al. November 9, 2 | 2004-11-09 |
| Chemical compounds App 20040198766 - Lackey, Karen Elizabeth ; et al. | 2004-10-07 |
| Compounds App 20040191210 - Glennon, Kimberley Caroline ; et al. | 2004-09-30 |
| Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 6,727,256 - Carter , et al. April 27, 2 | 2004-04-27 |
| Substituted aza-oxindole derivatives App 20040072836 - Harris, Philip Anthony ; et al. | 2004-04-15 |
| Heterocyclic compounds Grant 6,713,485 - Carter , et al. March 30, 2 | 2004-03-30 |
| Cancer treatment method App 20040053946 - Lackey, Karen Elizabeth ; et al. | 2004-03-18 |
| Oxindole derivatives App 20030225090 - Harris, Philip Anthony ; et al. | 2003-12-04 |
| Substituted oxindole derivatives as tyrosine kinase inhibitors App 20030195234 - Dickerson, Scott Howard ; et al. | 2003-10-16 |
| Substituted aza-oxindole derivatives Grant 6,624,171 - Harris , et al. September 23, 2 | 2003-09-23 |
| Heterocyclic compounds App 20030176451 - Carter, Malcolm Clive ; et al. | 2003-09-18 |
| Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects App 20030069430 - Davis, Stephen Thomas ; et al. | 2003-04-10 |
| Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors Grant 6,541,503 - Davis , et al. April 1, 2 | 2003-04-01 |
| Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors App 20030004351 - Davis, Stephen Thomas ; et al. | 2003-01-02 |
| 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors Grant 6,498,176 - Lackey , et al. December 24, 2 | 2002-12-24 |
| Heterocyclic compounds App 20020147205 - Carter, Malcolm Clive ; et al. | 2002-10-10 |
| 3-(Anilinomethylene)oxindoles App 20020099071 - Glennon, Kimberley Caroline ; et al. | 2002-07-25 |
| Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors Grant 6,369,086 - Davis , et al. April 9, 2 | 2002-04-09 |
| 3-(anilinomethylene) oxindoles Grant 6,350,747 - Glennon , et al. February 26, 2 | 2002-02-26 |
| Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases Grant 6,268,391 - Dickerson , et al. July 31, 2 | 2001-07-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 